Glutathione depletion and increased apoptosis rate in human cystinotic proximal tubular cells by Laube, Guido F et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2006
Glutathione depletion and increased apoptosis rate in human cystinotic
proximal tubular cells
Laube, Guido F; Shah, Vanita; Stewart, Victoria C; Hargreaves, Iain P; Haq, Mushfequr R; Heales,
Simon J R; van’t Hoff, William G
Abstract: We have determined levels of glutathione (GSH), ATP, mitochondrial complex activity and
apoptosis rate in proximal tubular cells (PTCs) exfoliated from urine in cystinotic (n=9) and control
(n=9) children. Intracellular GSH was significantly depleted in cystinotic PTCs compared with con-
trols (6.8nmol GSH/mg protein vs 11.8nmol GSH/mg protein; P<0.001), but there were no significant
differences in mitochondrial complex activities or ATP levels under basal conditions. Cystinotic PTCs
showed significantly increased apoptosis rate. After PTCs had been stressed by hypoxia, there was fur-
ther depletion of GSH in cystinotic and control PTCs (2.4nmol GSH/mg protein vs 7.2nmol GSH/mg
protein; P<0.001). Hypoxic stress led to increased complexI and complexIV activities in control but
not in cystinotic PTCs. ATP levels were significantly reduced in cystinotic PTCs after hypoxic stress
(12.2nmol/mg protein vs 26.9nmol/mg protein; P<0.001). GSH depletion occurs in this in vitro model
of cystinotic PTCs, is exaggerated by hypoxic stress and may contribute to reduced ATP and failure to
increase complexI/IV activities. Apoptotic rate is also increased, and these mechanisms may contribute
to cellular dysfunction in cultured, human cystinotic PTCs
DOI: https://doi.org/10.1007/s00467-006-0005-x
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-156601
Journal Article
Published Version
Originally published at:
Laube, Guido F; Shah, Vanita; Stewart, Victoria C; Hargreaves, Iain P; Haq, Mushfequr R; Heales,
Simon J R; van’t Hoff, William G (2006). Glutathione depletion and increased apoptosis rate in human
cystinotic proximal tubular cells. Pediatric Nephrology, 21(4):503-509.
DOI: https://doi.org/10.1007/s00467-006-0005-x
Pediatr Nephrol (2006) 21: 503–509
DOI 10.1007/s00467-006-0005-x
ORIGINAL ARTICLE
Guido F. Laube . Vanita Shah . Victoria C. Stewart .
Iain P. Hargreaves . Mushfequr R. Haq .
Simon J. R. Heales . William G. van’t Hoff
Glutathione depletion and increased apoptosis rate in human
cystinotic proximal tubular cells
Received: 22 March 2005 / Revised: 26 September 2005 / Accepted: 28 September 2005 / Published online: 1 March 2006
# IPNA 2006
Abstract We have determined levels of glutathione
(GSH), ATP, mitochondrial complex activity and apoptosis
rate in proximal tubular cells (PTCs) exfoliated from urine
in cystinotic (n=9) and control (n=9) children. Intracellular
GSH was significantly depleted in cystinotic PTCs
compared with controls (6.8 nmol GSH/mg protein vs
11.8 nmol GSH/mg protein; P<0.001), but there were no
significant differences in mitochondrial complex activities
or ATP levels under basal conditions. Cystinotic PTCs
showed significantly increased apoptosis rate. After PTCs
had been stressed by hypoxia, there was further depletion
of GSH in cystinotic and control PTCs (2.4 nmol GSH/mg
protein vs 7.2 nmol GSH/mg protein; P<0.001). Hypoxic
stress led to increased complex I and complex IV activities
in control but not in cystinotic PTCs. ATP levels were
significantly reduced in cystinotic PTCs after hypoxic
stress (12.2 nmol/mg protein vs 26.9 nmol/mg protein;
P<0.001). GSH depletion occurs in this in vitro model of
cystinotic PTCs, is exaggerated by hypoxic stress and may
contribute to reduced ATP and failure to increase
complex I/IV activities. Apoptotic rate is also increased,
and these mechanisms may contribute to cellular dysfunc-
tion in cultured, human cystinotic PTCs.
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Introduction
Cystinosis is a rare, autosomal, recessive disorder char-
acterised by defective lysosomal transport of cystine,
leading to intra-lysosomal cystine accumulation [1–7].
Infantile nephropathic cystinosis is characterised by
severe renal proximal tubular dysfunction [renal Fanconi
syndrome (FS)], but the link between the intra-lysosomal
cystine accumulation and the FS is still unclear. Normal
rabbit and rat proximal tubules loaded with cystine by
incubation with cystine dimethyl ester (CDME) have
intracellular cystine concentrations similar to those of
cystinotic cells and exhibit defective tubular transport as
in the FS [8–10]. CDME-loaded tubules exhibit reduced
ATP levels and have impaired oxygen consumption [9,
10], consistent with defective oxidative phosphorylation
and/or mitochondrial dysfunction. Defects in mitochon-
drial function have also been found in animal models of
FS, e.g. tyrosinaemia, and genetic mitochondrial dis-
orders can lead to a profound FS [11, 12]. Cystine has
also been found to directly inhibit Na+-dependent co-
transporters in cystine-loaded proximal tubule cells [13].
Recent work has indicated that cultured fibroblasts from
cystinotic patients exhibit an increased apoptotic rate
compared with those from healthy subjects and that this
can be negated by pre-treatment with cysteamine [14].
The tri-peptide glutathione (GSH) has a major role in
cellular redox reactions and thiol-ether formation. Under
hypoxic stress, GSH is oxidised to GSH-disulphide,
defining a rupture between pro-oxidant and anti-oxidant
systems. The existence of such oxidative stress is
established in patients with chronic renal disease [15].
Furthermore, the de novo synthesis of the key cellular
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antioxidant, GSH, may be dependent on cytosolic cystine/
cysteine availability [16].
In order to study proximal tubular cell (PTC) dysfunc-
tion in cystinosis we used an in vitro model by culturing
and characterising PTCs from cystinotic patients and
controls [17]. We hypothesised that mitochondrial dys-
function and increased apoptosis rate might contribute to
the FS in cystinosis. We also postulated that GSH status
might be compromised in cystinotic cells. After growing
and characterising PTCs from patients and controls, we
studied mitochondrial function, GSH status and the rate of
apoptosis.
Methods
Cell culture and characterisation
PTCs were collected from nine early-onset cystinosis
patients (prior to end stage renal failure; mean creatinine
86μmol/l) and nine children in a control group, consisting of
patients from the cardiac intensive care unit, 2 days after
surgery [17]. These “control” children were selected as they
routinely had urethral catheters but were haemodynamically
stable and had no clinical or biochemical evidence of renal
impairment at the time of study. All the cystinosis patients
had been on long-term treatment with cysteamine 40–60mg/
kg per day, with trough leucocyte cystine concentrations
maintained generally at <1 nmol ½ cystine/mg protein. All
participating families provided informed written consent,
and the study received ethical approval. Cells were frozen in
liquid nitrogen at various stages of culture prior to
experiments. Cells exfoliated in the children’s urine were
cultured and characterised as predominantly PTCs as
previously described [17, 18]. Cells were grown under
basal (21%) or hypoxic conditions (3% oxygen for 48 h, a
value previously shown to elucidate a stress response [19]).
Cells used in the studies were taken from confluent
monolayers in cell passages 1–3. PTCs from individual
patients were treated as separate isolates, and each exper-
iment was repeated in triplicate.
Measurement of intracellular ATP and glutathione
PTCs were grown in 25 cm2 flasks until confluent and then
washed twice with phosphate-buffered saline PBS solution.
Perchloric acid (0.4 M) (Aristar, BDH Laboratory Supplies
England) was added to the flask [to destroy the cell
membrane, as the supernatant fraction contains the intra-
cellular content (including ATP)], which was left on ice for
15 min. After being transferred to an Eppendorf tube, the
sample was centrifuged and the supernatant decanted. The
pH was adjusted to a value of 6.0–7.0 with potassium
hydroxide (KOH, 3 M) (Sigma, St. Louis, USA). After
centrifugation, the supernatant was transferred to a new
Eppendorf tube ready for the ATP determination, measured
by high-performance liquid chromatography [20]. For
determination of GSH, PTCs were grown in 25 cm2 flasks
until confluent and again scraped in PBS. After centrifu-
gation the supernatant was aspirated and the cell pellet
resuspended in PBS before being frozen at −70°C degrees
prior measurement of total GSH [21]. Spiking of samples
with 2.5 μM GSH revealed a 98±2% (n=6) recovery of
GSH. Furthermore, the GSH concentration in the acid
extracts was stable for 24 h at room temperature and for at
least 1 year at −70°C [22]).
Enzyme activity determination
(measurement of mitochondrial complexes I to IV)
PTCs were grown in 75 cm2 flasks until confluent and then
harvested, pelleted and resuspended in 0.25 M sucrose
solution containing 2 mM HEPES, pH 7.2 (Sigma). After
three cycles of freeze-thawing to lyse membranes, mito-
chondrial enzymes [NADH CoQ1 reductase (complex I;
EC 1.6.5.3); succinate dehydrogenase (complex II; EC
1.3.5.1); ubiquinol-cytochrome c reductase (complex III;
EC 1.10.2.2); cytochrome c oxidase (complex IV; EC
1.9.3.1); citrate synthase (EC 4.1.3.7)] were assayed
spectrophotometrically by established methods [23–26].
Enzyme activities were expressed as nanomoles per minute
per milligramme of protein, except that of cytochrome c
oxidase, which was expressed as the first-order rate
constant k per minute per milligramme of protein. The
activity of citrate synthase (CS) was used as a marker of
mitochondrial enrichment.
Measurement of apoptosis rate
Induction and measurements of apoptosis were performed
with commercially available reagents. PTCs were grown in
25 cm2 flasks until confluent and then exposed to apoptotic
triggers: TNF-α (2 ng/ml; Cell Sciences, USA) with
actinomycin-D (2.5 μg/ml; Sigma) and anti-Fas antibody
(500 ng/ml; TNB Laboratories, Canada) for 16 h. After
exposure, the PTCs were harvested and caspase-3 activity
was measured with the caspase-3 colorimetric activity
assay kit [CN Bioscience (UK)]. We then used the terminal
deoxynucleotidyl transferase-mediated dUTP nick end
labelling (TUNEL) method, which utilises terminal de-
oxynucleotidyl transferase to label the ends of double-
stranded DNA breaks, which occur in apoptotic cells, with
fluorescein isothiocyanate (FITC)-conjugated dUTP. PTCs
were grown, fixed and permeabilised with methanol/
acetone (1:1) for 5 min on ice and stained using the
TUNEL enzymatic labelling assay (Roche Diagnostics,
Mannheim, Germany). We counted the cells by fluores-
cence microscopy, scoring at least three view fields for
fluorescence in triplicate after counting the same field
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by light microscopy. The apoptosis rate is given as a
percentage and results from the total number of PTCs that
fluoresce divided by the total PTCs in the field.
Statistics
Descriptive data are presented as geometric means and
ranges and compared using unpaired Student’s two-tailed
t-tests.
Results
Cells became confluent after 2–4 weeks, were character-
ised as predominantly PTC phenotype and accumulated
cystine as previously demonstrated [17, 18]. Cells were
studied between passages 1 and 3, and there was no
significant effect of passage number on any of the results
presented below (data not shown).
Basal conditions (21% oxygen)
The results are summarised in Figs. 1 and 2 (data relative to
citrate synthase to correct for mitochondrial enrichment).
Individual variation among cystinotic and control patient
samples was small and statistically insignificant. GSH
levels were significantly lower in cystinotic PTCs than in
controls (6.8±2.8 nmol GSH/mg protein vs 11.8±2.8 nmol
GSH/mg protein; P<0.001; Fig. 1a). There were no
significant differences in ATP levels (Fig. 1b) or in
mitochondrial complex activities in cystinotic PTCs
compared to controls under basal conditions (Fig. 2).
Hypoxic conditions (3% oxygen)
Hypoxic stress was associated with a further significant
deletion in GSH status in the cystinotic PTCs compared
with control PTCs (2.4±0.9 nmol GSH/mg protein vs 7.2±
2.5 nmol GSH/mg protein, P<0.001; Fig. 1a). Additionally,
ATP levels were significantly decreased when compared
with those of control PTCs (12.2±3.9 nmol/mg protein vs
26.9±8.2 nmol/mg protein, P<0.001; Fig. 1b). In control
cells, hypoxia was associated with an increase in complex I
(0.067±0.017 vs 0.034±0.011, P<0.001; Fig. 2a) and
complex IV (0.0074±0.003 vs. 0.0024±0.0008, P<0.001;
Fig. 2b) activities. However, in the cystinotic PTCs,
mitochondrial complexes I and IV activities were not
significantly different from those under basal conditions
(Fig. 2) (complex I basal activity 0.037±0.023 vs complex I
hypoxic activity 0.034±0.011; complex IV basal activity
0.0038±0.0015 vs complex IV hypoxic activity 0.0024±
0.0008). In all cases there were no significant changes in
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Fig. 1 Glutathione (a) in nanomoles/mg protein and ATP (b) in
nanomoles/mg protein in cystinotic PTCs (black) and control PTCs
(white) (mean ± SD) after PTCs were grown under basal conditions
(21% oxygen) and under hypoxic conditions (3% oxygen).
Statistical comparison (Student’s two-tailed t-test) between patients
and controls for GSH (basal/hypoxia) and ATP (hypoxia): P<0.001
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Fig. 2 Mitochondrial function in cystinotic PTCs (black) and
control PTCs (white) (mean ± SD) after PTCs were grown under
basal conditions (21% oxygen) and under hypoxic conditions (3%
oxygen). a Mitochondrial complex I activity related to citrate
synthase. b Mitochondrial complex IV activity related to citrate
synthase. Statistical comparison (Student’s two-tailed t-test) between
patients and controls for mitochondrial complex I/IV activity
(hypoxia): P<0.001
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complexes II and III. The variable effects of hypoxia on
complex I and IV activities between cystinotic and control
cells compared with the activities of complexes II and III
are consistent with a specific effect on complexes I and IV
rather than a generalised loss of mitochondrial or whole-
cell viability.
Apoptosis rate in cystinotic PTCs
Apoptosis rates, induced by TNF-α or anti-Fas antibody
and measured by TUNEL and caspase-3 activity, are
summarised in Table 1. The apoptosis rate in cystinotic
PTCs, as determined by caspase-3 activity, was signifi-
cantly (P<0.001) increased both with and without anti-Fas
antibody trigger. Measurements also showed higher, but
not significant, caspase-3 levels in cystinotic PTCs when
triggered with TNF-α. Similar results were obtained when
PTCs were analysed by TUNEL, and significant (P<0.001)
differences could be shown using anti-Fas antibody and
TNF-α. Immunohistochemistry demonstrated an increased
apoptosis rate in cystinotic PTCs compared with control
PTCs (data not shown).
Discussion
The pathogenesis of proximal tubular dysfunction in
cystinosis is not fully understood. Generalised proximal
tubular dysfunction (FS) can occur in a heterogeneous
group of genetic disorders and acquired diseases and can
also be caused by drugs or toxins. Avariety of pathogenetic
mechanisms has been described (reviewed in [27]). There
is increasing evidence that defects in the endocytic
pathway are implicated in the abnormal urinary losses of
low molecular weight proteins in FS (e.g. in Dent’s disease
and in Lowe’s syndrome [28]). Abnormalities in mito-
chondrial function or in sodium-coupled co-transport have
been suggested as mediators of the abnormal electrolyte
losses. We suggest that some of these mechanisms may co-
exist in the various disorders leading to the renal FS.
In cystinosis, data from an animal model showed
impaired mitochondrial function and oxidative phosphor-
ylation to be responsible for the FS [8–10]. In addition,
human cystinotic fibroblasts show increased apoptosis rate,
suggesting that this may also occur in PTCs [14]. Elec-
trophysiological studies have shown inhibition of Na+-
dependent transporters in cystine-loaded human renal cells
[13]. However, these studies have been undertaken in cells
loaded with CDME in which cystinosin function was
normal and, therefore, may not be relevant to native
cystinotic cells in which the function of cystinosin is
defective. A mouse knock-out model of cystinosis exhibits
cystine accumulation but no tubulopathy, limiting its
potential as a model in which to study the pathogenesis
of FS [29]. We therefore undertook studies in human PTCs
cultured from the urine of cystinosis children and controls
[17]. Cystine levels in the cystinotic PTCs were signifi-
cantly elevated compared with the control PTCs and
similar to those found in leucocytes from cystinotic patients
[17, 18].
We observed apparent loss of GSH status in cystinotic
PTCs under basal conditions; however, mitochondrial
complex activities and ATP levels were unchanged.
Hypoxic stress led to a decrease in GSH status in control
cells and a further decrease in cystinotic cells. Our previous
experience with other cell types frozen at −70°C has not
identified any apparent effects of storage time on GSH
status. However, in this series of experiments utilising
cystinotic cells, it is possible that high disulphide exchange
secondary to the high cystine disulphide pool may have
contributed to loss of GSH status. It is possible that this
might explain some of the differences observed between
the cystinotic and control cell results. Previous data on
GSH levels in cystinosis fibroblasts have shown a decrease,
in one study [30], but no statistical difference from controls
in two other studies [31, 32], although in the latter, stress
led to significant GSH depletion in cystinotic cells [32]. It
is possible that these differences relate to our use of PTCs
(a cell type primarily affected in cystinosis) rather than
fibroblasts. It is known that discrepancies can occur
between studies undertaken in fibroblasts and those
undertaken in target organ tissues (e.g. muscle in mito-
chondrial disorders [33]).
An increase in urinary 5-oxoproline (pyroglutamate) has
previously been demonstrated in cystinotic patients [34],
and it has been speculated that this might arise from
perturbation of the γ-glutamyl cycle, which could be
associated with GSH depletion. Cystinotic fibroblasts
exhibited raised pyroglutamate levels, compared with
controls, and the difference became more marked after
cells were stressed [32]. However, known inherited defects
of the γ-glutamyl cycle are not known to be associated with
Fanconi syndrome, so it is not yet clear how these previous
observations are related to the pathogenesis of the tubular
dysfunction.
Table 1 Apoptosis rate in cystinotic PTCs and in control PTCs (mean ± SD) measured by caspase-3 activity (in picomoles/minute per
milligramme) and TUNEL (as a percentage)
Parameter No trigger TNF-α Anti-Fas antibody
Caspase-3 activity Patients (1)90.8±21.7 66.1±14.4 (4)85.7±17.4
Controls (1)49±15.2 52.2±22.2 (4)47.4±16.8
TUNEL Patients (2)15.5±3.1 (3)18.1±5.3 (5)20.5±5.2
Controls (2)7.3±1.5 (3)9.3±1.9 (5)10.5±3.2
(1–5)Statistical comparison (Student’s two-tailed t-test) between patients and controls: P<0.001
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GSH biosynthesis is likely to be dependent on a
cytosolic supply of cysteine/cystine [15, 16]. Although
intracellular cystine is elevated in cystinotic cells, it is
compartmentalised within lysosomes secondary to defec-
tive/absent cystinosin function, and previous work on
cystinotic fibroblasts has indicated normal cytosolic levels
of cystine and cysteine [35]. The exact mechanism
whereby GSH status could be compromised in cystinotic
PTCs is not yet known. Further evidence of the role of
GSH depletion in the pathogenesis of proximal tubular
transport would come from studies of the expression and
function of co-transporters in this model of cystinotic PTCs
and the effect of supplementing GSH in this system.
GSH has a number of key cellular roles, including post-
translational protein modification and xenobiotic detoxifi-
cation, and it acts as a major antioxidant. Deficiency of
GSH has also been implicated in other forms of the renal
FS that occurs after ifosfamide therapy or in Balkan
endemic nephropathy (BEN), in which ochratoxin A is
considered to be the environmental toxin [36]. Ifosfamide
toxicity may be mediated by its interaction with γ-glutamyl
transpeptidase and by hepatic metabolism to chloroacetal-
dehyde [37]. Incubation of chloroacetaldehyde with
isolated human renal proximal tubules was associated
with cellular depletion of GSH, coenzyme A, acetyl-
coenzyme A and ATP [38]. Wistar rats injected with
ifosfamide develop renal FS, associated with GSH deple-
tion [38]. Concurrent treatment with melatonin attenuates
the GSH depletion and attenuates the renal FS [38].
Ochratoxin A exposure to rat proximal tubular cells led to
elevation of reactive oxygen species and depletion of
cellular GSH [39]. Ochratoxin A also increases caspase-3
and induces apoptosis in human proximal tubular cells
[39]. Moreover, augmenting intracellular GSH may have a
protective effect. Rat proximal tubular cells, transfected to
over express the dicarboxylate carrier (thereby increasing
mitochondrial GSH), exhibited less apoptosis after expo-
sure to tert-butyl hydroperoxide or S-(1,2-dichlorovinyl)-
L-cysteine than did wild-type cells [40].
Depletion of GSH is also associated with the initiation of
apoptosis [41]. In support of this, we also observed
increased an apoptosis rate in cystinotic PTCs after
triggering the cells with TNF-α and anti-Fas. Triggering
the PTCs with TNF-α was not as effective as with anti-Fas
antibody or even without the use of any trigger, but, as
shown in endothelial cells, TNF-α may not be a successful
trigger in all types of cells [42].
It is increasingly recognised that apoptosis is linked to
intracellular biochemical events. In particular, mitochon-
dria have a key role in cell death [42–46]. Firstly cells
accumulate effector molecules directly acting on mito-
chondria and causing mitochondrial membrane perme-
abilisation. This is followed by decision, the effective act of
mitochondrial membrane permeabilisation and degrada-
tion, the triggering of a series of catabolic reactions due to
the release of factors (such as cytochrome c) that induce
cell death, either by apoptosis or by necrosis. Park and
Thoene first described increased apoptotic rates in cultured
cystinotic fibroblasts [14] and speculated that apoptosis
may be a key factor in the development of the multisystem
phenotype of cystinosis [14]. Our data in proximal tubular
cells support their data, but further work is needed to
understand the contribution of each of these different
pathogenetic mechanisms in cystinosis.
We found no evidence, in cystinotic cells grown under
basal conditions, of impaired activity of any of the
components of the mitochondrial electron transport chain.
However, the assays employed will only detect: (a)
irreversible damage that is sufficient to manifest itself
under the saturating assay conditions employed or (b) gross
changes in the steady state level of a particular enzyme
complex. Thus, reversible inhibition of the electron
transport chain, e.g. by nitric oxide [47], that may occur
within the intact cell, will not be detected. Whilst there was
no detectable evidence for an impairment of the mitochon-
drial electron transport chain, it is entirely possible that
other factors related to mitochondrial function are
perturbed in cystinotic cells, e.g. ATP synthetase, mito-
chondrial membrane potential and permeability transition.
In contrast to the control cells, in the cystinotic cells
hypoxia was associated with a loss of ATP. Inspection of
the activities of the mitochondrial respiratory chain
complexes revealed that, in the control cells, hypoxia was
associated with increased activities of mitochondrial
complexes I and IV. Increases in the specific activities of
complexes I and IV have also been demonstrated in other
model systems of oxidative stress, including GSH defi-
ciency, neurodegenerative disorders and septic shock [48–
51]. These studies suggest that, when molecular oxygen is
limiting, there is normally a compensatory increase in
complexes I and IVof the electron transport chain in order
to maintain the availability of ATP. Our data, however,
suggest that in cystinotic cells this protective mechanism
may be lost. Sodium-dependent co-transport in the prox-
imal tubule depends on a sodium gradient, maintained by
adequate function of basolateral ATP-driven NaK ATPase.
Mitochondrial dysfunction with subsequent ATP depletion
will secondarily reduce NaK ATPase function. In addition,
recent work, in a rat model of ischaemic tubular damage,
found that ATP depletion disrupted the ankyrin–spectrin
complex that holds NaK ATPase to the basolateral
membrane, leading to its mislocation to the cytosol [52].
The net result of reduced NaK ATPase function is a
reduced gradient for sodium-coupled co-transport and,
hence, increased urinary solute losses.
In conclusion, this study has demonstrated, in human
cystinotic proximal tubular cells, depletion of GSH and an
increased susceptibility for apoptotic cell death. In addi-
tion, our data suggest that, under hypoxic stress, cystinotic
cells may have lost the ability to up-regulate key
components of the mitochondrial electron transport chain
and, hence, preserve cellular ATP. The link between intra-
lysosomal cystine accumulation, secondary to defective
cystinosin function, and GSH depletion remains unclear.
Whatever the mechanism, we speculate that GSH defi-
ciency and increased apoptosis rate are implicated in the
pathogenesis of proximal tubular dysfunction in cystinosis.
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